- Home
- TRC vs YDES Comparison
TRC vs YDES Comparison
Compare TRC & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | TRC | YDES |
|---|---|---|
| Founded | 1843 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Real Estate | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.4M | 476.8M |
| IPO Year | 1995 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TRC | YDES |
|---|---|---|
| Price | $16.48 | $4.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 97.7K | ★ 361.4K |
| Earning Date | 11-05-2026 | 08-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $37,830,000.00 | N/A |
| Revenue This Year | $10.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $166.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.31 | $1.70 |
| 52 Week High | $21.31 | $17.99 |
Technical Indicators
Market Signals| Indicator | TRC | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 53.99 | 44.05 |
| Support Level | $15.86 | $2.33 |
| Resistance Level | $16.88 | $5.15 |
| Average True Range (ATR) | 0.39 | 0.98 |
| MACD | 0.02 | -0.31 |
| Stochastic Oscillator | 67.89 | 21.54 |
Price Performance
Historical ComparisonAbout TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company. It has six reporting segments: Real Estate - Commercial/Industrial, Multifamily, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.